These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33726585)
1. A comparative review of current topical antibiotics for impetigo. Galindo E; Hebert AA Expert Opin Drug Saf; 2021 Jun; 20(6):677-683. PubMed ID: 33726585 [TBL] [Abstract][Full Text] [Related]
2. Topical Ozenoxacin Cream 1% for Impetigo: A Review. Schachner L; Andriessen A; Bhatia N; Grada A; Patele D J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625 [TBL] [Abstract][Full Text] [Related]
3. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections. Yang LP; Keam SJ Drugs; 2008; 68(6):855-73. PubMed ID: 18416589 [TBL] [Abstract][Full Text] [Related]
4. Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials. Hebert AA; Albareda N; Rosen T; Torrelo A; Grimalt R; Rosenberg N; Zsolt I; Masramon X J Drugs Dermatol; 2018 Oct; 17(10):1051-1057. PubMed ID: 30365584 [TBL] [Abstract][Full Text] [Related]
5. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo. Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Koning S; van der Wouden JC; Chosidow O; Twynholm M; Singh KP; Scangarella N; Oranje AP Br J Dermatol; 2008 May; 158(5):1077-82. PubMed ID: 18341664 [TBL] [Abstract][Full Text] [Related]
8. Ozenoxacin: A Novel Topical Quinolone for Impetigo. Wren C; Bell E; Eiland LS Ann Pharmacother; 2018 Dec; 52(12):1233-1237. PubMed ID: 29962213 [TBL] [Abstract][Full Text] [Related]
9. Ozenoxacin 1% cream (Xepi) for impetigo. Med Lett Drugs Ther; 2019 Apr; 61(1570):63-64. PubMed ID: 31169810 [No Abstract] [Full Text] [Related]
10. Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial. Rosen T; Albareda N; Rosenberg N; Alonso FG; Roth S; Zsolt I; Hebert AA JAMA Dermatol; 2018 Jul; 154(7):806-813. PubMed ID: 29898217 [TBL] [Abstract][Full Text] [Related]
11. Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections. Yang LP; Keam SJ Am J Clin Dermatol; 2008; 9(6):411-3. PubMed ID: 18973410 [TBL] [Abstract][Full Text] [Related]
12. Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents. Torrelo A; Grimalt R; Masramon X; Albareda López N; Zsolt I Dermatology; 2020; 236(3):199-207. PubMed ID: 31958794 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus. Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674 [TBL] [Abstract][Full Text] [Related]
14. Ozenoxacin: a review of preclinical and clinical efficacy. Vila J; Hebert AA; Torrelo A; López Y; Tato M; García-Castillo M; Cantón R Expert Rev Anti Infect Ther; 2019 Mar; 17(3):159-168. PubMed ID: 30686133 [TBL] [Abstract][Full Text] [Related]